Company / Operating Cash Flow per Share
Co-Diagnostics, Inc. Operating Cash Flow per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$26.45
FY2025
5-year range
-$26.45 / $1.21
FY2021-FY2025
Trend
-2735.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share changed -2735% YoY in FY2025, a notable deviation from the 8-year average annual change of -326%.
Based on SEC 10-K filings.
-26.45 in FY2025.
Declined from $-0.72 to $-26.45 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Co-Diagnostics, Inc.'s operating cash flow per share has declined for 3 consecutive years.
- In FY2025, operating cash flow per share decreased 2735.4% year-over-year.
- Peak operating cash flow per share was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$26.45 | -2735.4% |
| FY2024 | -$0.93 | -30.4% |
| FY2023 | -$0.72 | -158.9% |
| FY2022 | $1.21 | +23.2% |
| FY2021 | $0.99 | +409.6% |
| FY2020 | -$0.32 | -0.9% |
| FY2019 | -$0.32 | -21.1% |
| FY2018 | -$0.26 | -96.3% |
| FY2017 | -$0.13 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026